Active08401609Private limited companyLondon

HEMOGENYX PHARMACEUTICALS PLC

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Hemogenyx Pharmaceuticals PLC: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Hemogenyx Pharmaceuticals PLC sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

HEMOGENYX PHARMACEUTICALS PLC is an active private limited company (company number 08401609) incorporated on 13 February 2013, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (group) but not yet parsed into this record.

There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.

Ownership and control

0 active · 2 other

No active person with significant control is registered.

AS
Mrs Alexis Sandler
Individual · since 5 October 2017 · ceased 4 October 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
VS
Dr Vladislav Sandler
Individual · since 5 October 2017 · ceased 4 October 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 13 February 201313 yrs ago
First accounts due: 13 November 20144365 days overdue
Confirmation statement due: 27 February 2027in 124 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Group

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 13 February 2013
Accounts past their due dateDue 13 November 2014

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

27 Feb 2027Confirmation statement duein 124 days
13 Nov 2014First accounts due4365 days overdue
13 Feb 2013Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 13 February 2013 · in Feb 2013.

Reminders for HEMOGENYX PHARMACEUTICALS PLC

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.